ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2088

Immature Dendritic Are Potent OC Precursors in RA and Are Targeted By RA-Specific Antibodies

Akilan Krishnamurthy1, Vijay Joshua2, Heidi Wähämaa3, Vivianne Malmström3, Khaled Amara1, Jimmy Ytterberg4 and Anca I Catrina3, 1Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, 2Unit of Rheumatology, Department of Medicine Solna, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, 3Rheumatology Unit, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden, 4Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: anti-CCP antibodies, bone biology and dendritic cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Biology and Pathology of Bone and Joint: Bone Remodeling

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose:

Immature dendritic cells (iDC) have been shown to act as OC precursors and are important cell players in the pathogenesis of RA. We aimed to investigate the relationship between iDC derived osteoclastogenesis and specific immunity in RA. 

Methods:

CD14+ monocytes from PB of ACPA+ RA patients and healthy individuals were first cultured in the presence of GM-CSF and IL-4 to generate iDC or in the presence of M-CSF to generate MΦ and then further differentiated to OC in the presence of RANKL and M-CSF. In parallel, cells were grown on osteoassay surfaces and bone resorption area was quantified by computer assisted image analysis. Mass spectrometry analysis was performed on different stages of differentiation of iDC and MΦ derived OC.  ACPA positive and negative polyclonal IgGs were isolated from synovial fluid (SF, n=26) and peripheral blood (PB, n=38) samples of RA patients. Cytokines were measured by cytometric bead arrays in cultures supernatants. Immunohistochemistry (IHC) was used to stain the OCs with murinized monoclonal ACPAs derived from single SF derived B cells. The effect of IL-8 inhibition was tested in the OC cultures.

Results:

Principal component analysis confirmed distinct proteomic profiles during OC maturation from iDC and MΦ, respectively. Vimentin significantly increased during iDC-OC maturation, with citrullinated vimentin peptides detectable in matured OCs. Polyclonal ACPAs enhanced osteoclastogenesis and bone resorption from iDC (fold increase of 1.6±0.2 for OC number and 2.0±0.3 for bone resorption area). Similar effect was observed when the iDC were derived from ACPA+ RA patients (fold increase of 2.3±0.9 for OC number and 2.6±0.1 for bone resorption area). PB derived ACPAs were equally effective with SF ACPAs. Increased osteoclastogenesis was associated with significantly higher levels of IL-8 levels in cultures supernatants (fold increase of 2.4±0.5). Immunohistochemistry demonstrated presence of cit peptides in both iDC precursors and iDC-derived mature OCs suggesting that citrullination is important for iDC-OC differentiation and maturation (Figure 6B). PAD2 and PAD4 showed faint staining in CD14 monocytes with increased staining intensity in both iDC precursors and more mature OCs. The importance of citrullination and PAD enzymes for iDC transdifferentiation was confirmed by a dose-dependent inhibition of OC differentiation using PADi in the presence of RANKL and M-CSF. IL-8 was the main cytokine detected in the culture supernatants of iDC-derived cultures.

Conclusion:

iDC can effeiciently transdifferentiate in OC and are targeted by RA specific antibodies.


Disclosure: A. Krishnamurthy, None; V. Joshua, None; H. Wähämaa, None; V. Malmström, None; K. Amara, None; J. Ytterberg, None; A. I. Catrina, None.

To cite this abstract in AMA style:

Krishnamurthy A, Joshua V, Wähämaa H, Malmström V, Amara K, Ytterberg J, Catrina AI. Immature Dendritic Are Potent OC Precursors in RA and Are Targeted By RA-Specific Antibodies [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/immature-dendritic-are-potent-oc-precursors-in-ra-and-are-targeted-by-ra-specific-antibodies/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/immature-dendritic-are-potent-oc-precursors-in-ra-and-are-targeted-by-ra-specific-antibodies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology